Skip to main content
. Author manuscript; available in PMC: 2025 May 1.
Published in final edited form as: Ann Intern Med. 2024 Oct 1;177(11):1462–1470. doi: 10.7326/M24-0859

Table 3.

Secondary and Exploratory Outcomes: Cardiometabolic Outcomes

TRE
SOC
Between Groups
Outcomes Baseline 3-Month Delta (95% CI) Percent Change Baseline 3-Month Delta (95% CI) Percent Change Delta
TRE-SOC
Percent Change

Body Composition
Weight, kg 89.94 (16.98) 86.96 (17.06) −2.98
(−4.11 to −1.84)
−3.3% 89.25 (16.48) 87.93 (16.23) −1.32
(−2.07 to −0.57)
−1.5% −1.66
(−3.00 to −0.32)
−1.8%
BMI, kg/m2 31.50 (4.06) 30.38 (4.37) −1.11
(−1.51 to −0.72)
−3.5% 30.95 (4.03) 30.55 (4.11) −0.39
(−0.66 to −0.13)
−1.3% −0.77
(−1.37 to −0.17)
−2.2%
Percent Body Fat, % 37.70 (6.90) 36.34 (7.35) −1.36
(−2.00 to −0.73)
−3.6% 38.62 (6.62) 38.51 (6.81) −0.11
(−0.71 to 0.49)
−0.4% −1.25
(−2.12 to −0.38)
−3.2%
Trunk Fat^, % 39.43 (5.88) 37.88 (6.50) −1.55
(−7.87 to −0.90)
−3.9% 40.33 (5.99) 40.18 (6.20) −0.15
(−0.83 to 0.53)
−0.4% −1.40
(−2.37 to −0.43)
−3.5%
Total Fat Mass, g 33263.73 (8306.52) 31023.51 (8490.32) −2240.22
(−3044.43 to 1376.01)
−6.7% 33572.58 (7634.67) 33163.47
(8027.05)
−409.11
(−1093.11 to 273.89)
−1.3% −1801.11
(−2871.06 to −731.16)
−5.4%
Total Lean Mass, g 52504.06 (11954.31) 52228.52 (12246.54) −275.53
(−773.69 to 222.62)
−0.5% 51544.89
(12182.13)
50977.86
(11991.96)
−567.03
(−1107.95 to −26.11)
−1.1% 291.50
(−434.31 to 1017.30)
+0.6%
Total BMC, g 2458.77 (543.28) 2462.99 (551.40) 4.22
(−11.54 to 19.98)
0.0% 2439.74
(548.23)
2442.64 (567.37) 2.89
(−13.55 to 19.34)
0.0% 1.32
(−21.18 to 23.82)
0.0%
Cardiometabolic Parameters
LDL Direct Cholesterol^
mmol/L 3.12 (1.07) 2.84 (1.03) −0.27
(−0.41 to −0.13)
−8.7% 3.02 (0.92) 2.98 (1.07) −0.04
(−0.16 to 0.09)
−1.2% −0.24
(−0.42 to −0.05)
−7.5%
mg/dL 120.48 (41.47) 110.00 (39.95) −10.48
(−15.83 to −5.13)
116.78 (35.62) 115.41 (41.44) −1.37
(−6.38 to 3.64)
−9.11
(−16.36 to −1.87)
LDL particle number, nmol/L 1527.87 (485.45) 1402.40 (490.54) −125.46
(−191.90 to −59.03)
−8.2% 1533.25 (423.01) 1485.25 (445.25) −48.00
(−104.64 to 8.64)
−3.1% −77.46
(−163.72 to 8.80)
−5.1%
HDL Cholesterol^
mmol/L 1.36 (0.40) 1.33 (0.35) −0.04
(−0.07 to 0.00)
−2.6% 1.39 (0.41) 1.39 (0.38) −0.01
(−0.05 to 0.03)
−0.7% −0.03
(−0.08 to 0.03)
−1.9%
mg/dL 52.70 (15.43) 51.33 (13.62) −1.37
(−2.90 to 0.15)
53.94 (16.01) 53.57 (14.85) −0.37
(−1.98 to 1.24)
−1.00
(−3.19 to 1.19)
Triglycerides^
mmol/L 1.66 (0.72) 1.57 (0.76) −0.09
(−0.22 to 0.05)
−5.3% 1.73 (0.87) 1.57 (0.65) −0.16
(−0.30 to 0.02)
−9.1% 0.07
(−10.7 to 23.02)
+3.8%
mg/dL 146.81 (63.49) 139.04 (67.19) −7.78
(−19.78 to 4.23)
152.87 (76.78) 138.93 (57.34) −13.94
(−26.17 to −1.82)
6.17
(−10.70 to 23.03)
hs-CRP^, mg/L 2.44 (2.65) 2.25 (2.53) −0.19
(−0.66 to 0.28)
−7.8% 2.63 (2.78) 2.54 (3.13) −0.09
(−0.89 to 0.71)
−3.4% −1.09
(−3.25 to 1.07)
−4.4%
SBP, mm/Hg 131.76 (15.22) 128.28 (12.27) −3.48
(−7.87 to 0.91)
−2.6% 127.89 (13.96) 126.17 (13.84) −1.72
(−5.91 to 2.47)
−1.3% −1.76
(−7.76 to 4.24)
−1.3%
DBP, mm/Hg 75.65 (10.93) 71.67 (10.23) −3.98
(−7.06 to −0.90)
−5.3% 74.88 (11.79) 73.44 (10.97) −1.44
(−3.81 to 0.93)
−1.9% −2.54
(−6.39 to 1.30)
−3.4%

Data displayed as Mean (SD) and Mean (95% Confidence Interval) for delta values. Paired t-tests were used to assess within-group changes and Mixed ANOVAs were used to assess changes between TRE and SOC (time x group) with age as a covariate. Body Composition was assessed via DXA body scan. N=54 per group for all outcomes except for the following: DXA measurements: SOC n=52; LDL particle number, n=52 per group (missing data due to lab error: interference); hs-CRP: TRE n=53. There was no pattern of missingness between groups (Supplemental Table 2). TRE = time-restricted eating, SOC = standard of care, BMI = body mass index, BMC = bone mineral content, LDL = low-density lipoprotein, HDL = high-density lipoprotein, hs-CRP = high sensitivity C-reactive protein, SBP = systolic blood pressure, DBP = diastolic blood pressure.